TrialJournal for immunotherapy of cancer2024

Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study.

Tingting Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.